ABSI — Absci Corp
The ticker ABSI represents Absci Corp, listed on NASDAQ.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the Absci Corp share price, or whether to buy ABSI? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ABSI that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ABSI is
Absci Corp (ABSI) is a cutting-edge biotechnology company that utilizes a proprietary AI-driven platform to revolutionize drug discovery and development. By facilitating the rapid generation of high-quality proteins and therapeutic candidates, Absci effectively shortens development timelines and lowers associated costs, establishing itself as a key innovator within the biopharmaceutical sector. The company's robust pipeline, complemented by strategic partnerships, underscores its commitment to advancing next-generation therapies that address critical medical needs and improve patient outcomes.
Absci Corp is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ABSI size and valuation
At roughly $1.76B, ABSI is a small-cap.
Earnings per share are negative at -0.79, so there is no meaningful price-to-earnings multiple to quote.
Beta is 2.28: historically it has moved more than the market.
ABSI over the past year
Over the past year ABSI has traded between $2.24 and $12.05, and the current price sits at 81% of that range.
The 50-day average is $9.07 against a 200-day average of $5.90 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $14.40, 41.6% above it. A target is an aggregate of opinions, not a measurement.
How Absci Corp (ABSI) is trading
Absci Corp (ABSI) is up 8.31% at $10.17. A move that large in a single session sits well outside the normal daily range for most stocks.
The session ranged from $9.51 to $10.26 — 7.3% of the share price — and the current price sits at 89% of that range.
It opened at $9.83 against a previous close of $9.39 — an opening gap of +4.7%, which almost always comes from information released outside trading hours.
The day's range extended past the previous close ($9.39) on both sides.
Volume ran near 4.2M shares, about $42.3M of stock changing hands.
Traded alongside ABSI
Names traded alongside ABSI in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ABSI
Two statistical models run over ABSI inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ABSI
- Name: Absci Corp
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ABSI — frequently asked questions
What is the market cap of ABSI?
Absci Corp has a market capitalisation of roughly $1.76B.
What is the 52-week range for ABSI?
ABSI has traded between $2.24 and $12.05 over the past year, with the current price at 81% of that range.
How much does ABSI stock cost today?
Absci Corp (ABSI) trades at $10.17, a change of +8.31% in the latest session.
Is ABSI up or down today?
ABSI is up 8.31% in the latest session, at $10.17.
What is the daily trading range for ABSI?
ABSI traded between $9.51 and $10.26 in the latest session, and currently trades at $10.17.
What is the trading volume for ABSI?
ABSI traded roughly 4.2M shares in the latest session.
Which exchange is ABSI listed on?
ABSI is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ABSI stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ABSI figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08